1. 177Lu-dotatate use in chronic kidney disease patients: A single center experience. Issue 3 (October 2021) Authors: Manohar, Sandhya; Kompotiatis, Panagiotis; Halfdanarson, Thorvardur R; Hobday, Timothy J; Thorpe, Matthew; Johnson, Geoffrey B; Kendi, Ayse Tuba; Leung, Nelson Journal: Journal of onco-nephrology Issue: Volume 5:Issue 3(2021) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment Outcomes of Well‐Differentiated High‐Grade Neuroendocrine Tumors. (8th February 2021) Authors: Liu, Alex J.; Ueberroth, Benjamin E.; McGarrah, Patrick W.; Buckner Petty, Skye A.; Kendi, Ayse Tuba; Starr, Jason; Hobday, Timothy J.; Halfdanarson, Thorvardur R.; Sonbol, Mohamad Bassam Journal: Oncologist Issue: Volume 26:Number 5(2021) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Whole-body 18-F-FDG-PET in patients with leptomeningeal disease and correlation with MRI. Issue 2 (February 2021) Authors: Panda, Ananya; Hintermeister, Holly A.; Hunt, Christopher H.; Kendi, Ayse Tuba Journal: Nuclear medicine communications Issue: Volume 42:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗